Taiko Nakazawa
Nagoya, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Optimal Primary Prophylaxis for Febrile Neutropenia During Neoadjuvant Cisplatin and 5-Fluorouracil Plus Docetaxel for Esophageal Cancer: A Retrospective Cohort Study.
Journal: Cancer medicine
Published: July 05, 2024
Safety and Efficacy of Gemcitabine Plus Cisplatin Against Recurrent/Metastatic Nasopharyngeal Carcinoma: A Retrospective Study.
Journal: Anticancer research
Published: September 25, 2023
Chronological improvement of survival in patients with advanced gastric cancer over 15 years.
Journal: Therapeutic advances in medical oncology
Published: September 10, 2023
Differential Efficacy of Targeted Monoclonal Antibodies in Left-Sided Colon and Rectal Metastatic Cancers.
Journal: Clinical colorectal cancer
Published: March 05, 2023
Clinical outcomes of patients diagnosed with cancer of unknown primary or malignancy of undefined primary origin who were referred to a regional cancer center.
Journal: International journal of clinical oncology
Published: October 04, 2022
The impact of combined PD-L1 positive score on clinical response to nivolumab in patients with advanced esophageal squamous cell carcinoma.
Journal: Esophagus : official journal of the Japan Esophageal Society
Published: April 23, 2022
Impact of omitting fluorouracil from FOLFIRI plus bevacizumab as second-line chemotherapy for patients with metastatic colorectal cancer.
Journal: Journal of cancer research and clinical oncology
Published: January 29, 2022
Clinical Impact of Oral Intake in Second-line or Third-line Chemotherapy for 589 Patients With Advanced Gastric Cancer: A Retrospective Cohort Study.
Journal: American journal of clinical oncology
Published: May 24, 2021
Ⅰ.Diagnosis and Treatment of MSI-H/dMMR Colorectal Cancer
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: December 03, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026